202 related articles for article (PubMed ID: 10964346)
1. Histopathology defines prognostic subsets of ganglioneuroblastoma, nodular.
Umehara S; Nakagawa A; Matthay KK; Lukens JN; Seeger RC; Stram DO; Gerbing RB; Shimada H
Cancer; 2000 Sep; 89(5):1150-61. PubMed ID: 10964346
[TBL] [Abstract][Full Text] [Related]
2. Revision of the International Neuroblastoma Pathology Classification: confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodular.
Peuchmaur M; d'Amore ES; Joshi VV; Hata J; Roald B; Dehner LP; Gerbing RB; Stram DO; Lukens JN; Matthay KK; Shimada H
Cancer; 2003 Nov; 98(10):2274-81. PubMed ID: 14601099
[TBL] [Abstract][Full Text] [Related]
3. The International Neuroblastoma Pathology Classification (the Shimada system).
Shimada H; Ambros IM; Dehner LP; Hata J; Joshi VV; Roald B; Stram DO; Gerbing RB; Lukens JN; Matthay KK; Castleberry RP
Cancer; 1999 Jul; 86(2):364-72. PubMed ID: 10421273
[TBL] [Abstract][Full Text] [Related]
4. International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
Shimada H; Umehara S; Monobe Y; Hachitanda Y; Nakagawa A; Goto S; Gerbing RB; Stram DO; Lukens JN; Matthay KK
Cancer; 2001 Nov; 92(9):2451-61. PubMed ID: 11745303
[TBL] [Abstract][Full Text] [Related]
5. Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee.
Shimada H; Ambros IM; Dehner LP; Hata J; Joshi VV; Roald B
Cancer; 1999 Jul; 86(2):349-63. PubMed ID: 10421272
[TBL] [Abstract][Full Text] [Related]
6. TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.
Shimada H; Nakagawa A; Peters J; Wang H; Wakamatsu PK; Lukens JN; Matthay KK; Siegel SE; Seeger RC
Cancer; 2004 Oct; 101(8):1873-81. PubMed ID: 15386308
[TBL] [Abstract][Full Text] [Related]
7. Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
Goto S; Umehara S; Gerbing RB; Stram DO; Brodeur GM; Seeger RC; Lukens JN; Matthay KK; Shimada H
Cancer; 2001 Nov; 92(10):2699-708. PubMed ID: 11745206
[TBL] [Abstract][Full Text] [Related]
8. Large cell neuroblastoma: a distinct phenotype of neuroblastoma with aggressive clinical behavior.
Tornóczky T; Kálmán E; Kajtár PG; Nyári T; Pearson AD; Tweddle DA; Board J; Shimada H
Cancer; 2004 Jan; 100(2):390-7. PubMed ID: 14716776
[TBL] [Abstract][Full Text] [Related]
9. [Clinicopathologic features of peripheral neuroblastic tumors].
Yang BF; Fu LB; He LJ
Zhonghua Bing Li Xue Za Zhi; 2013 May; 42(5):305-10. PubMed ID: 24004586
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of International Neuroblastoma Pathology Classification in localized resectable peripheral neuroblastic tumors: a histopathologic study of localized neuroblastoma European Study Group 94.01 Trial and Protocol.
Navarro S; Amann G; Beiske K; Cullinane CJ; d'Amore ES; Gambini C; Mosseri V; De Bernardi B; Michon J; Peuchmaur M;
J Clin Oncol; 2006 Feb; 24(4):695-9. PubMed ID: 16446343
[TBL] [Abstract][Full Text] [Related]
11. Characteristics and outcome of patients with ganglioneuroblastoma, nodular subtype: a report from the INRG project.
Angelini P; London WB; Cohn SL; Pearson AD; Matthay KK; Monclair T; Ambros PF; Shimada H; Leuschner I; Peuchmaur M; Irwin MS; Baruchel S
Eur J Cancer; 2012 May; 48(8):1185-91. PubMed ID: 22137163
[TBL] [Abstract][Full Text] [Related]
12. Conventional versus modified morphologic criteria for ganglioneuroblastoma. A review of cases from the Pediatric Oncology Group.
Joshi VV; Cantor AB; Altshuler G; Cohen LJ; Larkin EW; Shuster JJ; Rao PV; Holbrook CT; Hayes FA; Castleberry RP
Arch Pathol Lab Med; 1996 Sep; 120(9):859-65. PubMed ID: 9140292
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: a report from the CCG and COG.
Okamatsu C; London WB; Naranjo A; Hogarty MD; Gastier-Foster JM; Look AT; LaQuaglia M; Maris JM; Cohn SL; Matthay KK; Seeger RC; Saji T; Shimada H
Pediatr Blood Cancer; 2009 Oct; 53(4):563-9. PubMed ID: 19530234
[TBL] [Abstract][Full Text] [Related]
14. Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group.
London WB; Castleberry RP; Matthay KK; Look AT; Seeger RC; Shimada H; Thorner P; Brodeur G; Maris JM; Reynolds CP; Cohn SL
J Clin Oncol; 2005 Sep; 23(27):6459-65. PubMed ID: 16116153
[TBL] [Abstract][Full Text] [Related]
15. Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study.
Schmidt ML; Lal A; Seeger RC; Maris JM; Shimada H; O'Leary M; Gerbing RB; Matthay KK
J Clin Oncol; 2005 Sep; 23(27):6474-80. PubMed ID: 16116154
[TBL] [Abstract][Full Text] [Related]
16. International neuroblastoma pathology classification adds independent prognostic information beyond the prognostic contribution of age.
Sano H; Bonadio J; Gerbing RB; London WB; Matthay KK; Lukens JN; Shimada H
Eur J Cancer; 2006 May; 42(8):1113-9. PubMed ID: 16624549
[TBL] [Abstract][Full Text] [Related]
17. Clinical and biological features of neuroblastic tumors: A comparison of neuroblastoma and ganglioneuroblastoma.
He WG; Yan Y; Tang W; Cai R; Ren G
Oncotarget; 2017 Jun; 8(23):37730-37739. PubMed ID: 28465480
[TBL] [Abstract][Full Text] [Related]
18. [Correlation between typing of peripheral neuroblastic tumors and prognosis: a clinicopathologic study of 135 cases].
YIN MZ; ZHANG ZD; MA J; SHEN P; CHEN JF; ZHANG HZ
Zhonghua Bing Li Xue Za Zhi; 2011 Mar; 40(3):151-5. PubMed ID: 21575383
[TBL] [Abstract][Full Text] [Related]
19. Proliferation marker KI-S5 discriminates between favorable and adverse prognosis in advanced stages of neuroblastoma with and without MYCN amplification.
Krams M; Hero B; Berthold F; Parwaresch R; Harms D; Rudolph P
Cancer; 2002 Feb; 94(3):854-61. PubMed ID: 11857322
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the prognostic factors relating to better clinical outcome in ganglioneuroblastoma.
Kubota M; Suita S; Tajiri T; Shono K; Fujii Y
J Pediatr Surg; 2000 Jan; 35(1):92-5. PubMed ID: 10646782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]